129 related articles for article (PubMed ID: 71401)
1. New method of immunotherapy for lung cancer.
Holmes EC; Ramming KP; Mink J; Coulson WF; Morton DL
Lancet; 1977 Sep; 2(8038):586-7. PubMed ID: 71401
[No Abstract] [Full Text] [Related]
2. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
[No Abstract] [Full Text] [Related]
3. Intrapleural BCG in operable lung cancer.
Lowe J; Iles PB; Shore DF; Langman MJ; Baldwin RW
Lancet; 1980 Jan; 1(8158):11-4. PubMed ID: 6101353
[TBL] [Abstract][Full Text] [Related]
4. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
5. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
[No Abstract] [Full Text] [Related]
6. [BCG and levamisole in the treatment of advanced forms of lung cancer].
Szafrański W
Pneumonol Pol; 1980 Nov; 48(11):779-82. PubMed ID: 7255219
[No Abstract] [Full Text] [Related]
7. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
Morishita M
Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
[No Abstract] [Full Text] [Related]
8. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
Banna P; Murabito R; Saggio A; Cordopatri F; Riggi M; Campo ME; Cinà C; Latteri S
Ital J Surg Sci; 1983; 13(2):133-7. PubMed ID: 6195126
[TBL] [Abstract][Full Text] [Related]
9. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
11. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
12. The treatment of lung cancer.
Zubrod CG; Selawry O
Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
[No Abstract] [Full Text] [Related]
13. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
14. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
16. Regional immunotherapy of lung cancer with intrapleural B.C.G.
McKneally MF; Maver C; Kausel HW
Lancet; 1976 Feb; 1(7956):377-9. PubMed ID: 55646
[TBL] [Abstract][Full Text] [Related]
17. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
Lachmann PJ; Grant RM; Freedman LS; Sikora K; Bleehen NM
Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
[No Abstract] [Full Text] [Related]
18. Oral administration of the methanol extraction residue of BCG (MER/BCG): a phase I study in non-oat cell lung cancer patients.
Bartal AH; Mordohovich D; Lichtig C; Mekori T; Robinson E
Int J Immunopharmacol; 1983; 5(4):329-34. PubMed ID: 6629593
[TBL] [Abstract][Full Text] [Related]
19. Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
Roeslin N; Lang JM; Morand G; Wihlm JM; Witz JP
Cancer Immunol Immunother; 1982; 13(3):174-5. PubMed ID: 6925982
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.
Gail MH
Chest; 1994 Dec; 106(6 Suppl):287S-292S. PubMed ID: 7988246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
